The Usefulness of Serum CA-125 Levels in the Prediction of Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma

Saygili U., Guclu S., Erten O.

OVARIAN CANCER: NEW RESEARCH, cilt.19, ss.203-216, 2009 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19
  • Basım Tarihi: 2009
  • Dergi Adı: OVARIAN CANCER: NEW RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.203-216
  • Anahtar Kelimeler: CA-125, ovarian carcinoma, cytoreduction, debulking, LONG-TERM SURVIVAL, INDEPENDENT PROGNOSTIC-FACTOR, NEOADJUVANT CHEMOTHERAPY, DEBULKING SURGERY, MONOCLONAL-ANTIBODY, RESIDUAL DISEASE, STAGE-III, CANCER, ASCITES, PNEUMOPERITONEUM
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Optimal cytoreduction is one of the most important prognostic factors in ovarian cancer. If optimal debulcing Could not be performed, the patients Survival would be bad and it should be considered alternative therapy options. The aim of this study is to investigate the predictive value of serum CA-125 levels to ability of optimal primary cytoreduction in patients with advanced epithelial ovarian carcinoma.